Logo image
ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier
Journal article   Open access   Peer reviewed

ALCAM (CD166) is involved in extravasation of monocytes rather than T cells across the blood–brain barrier

Ruth Lyck, Marc-André Lécuyer, Michael Abadier, Christof Wyss, Christoph Matti, Maria Rosito, Gaby Enzmann, Thomas Zeis, Laure Michel, Ana García Martín, …
Journal of cerebral blood flow and metabolism, Vol.37(8), pp.2894-2909
08/2017
DOI: 10.1177/0271678X16678639
PMCID: PMC5536797
PMID: 28273717
url
https://doi.org/10.1177/0271678X16678639View
Published (Version of record) Open Access

Abstract

Activated leukocyte cell adhesion molecule (ALCAM) has been proposed to mediate leukocyte migration across the blood-brain barrier (BBB) in multiple sclerosis or experimental autoimmune encephalomyelitis (EAE). Here, we confirmed vascular ALCAM expression in human brain tissue samples in situ and on two different human in vitro BBB models. Antibody-mediated inhibition of ALCAM reduced diapedesis of human CD4+ Th1 but not of Th17 cells across the human BBB in vitro. In accordance to human Th1 cells, mouse Th1 cells showed reduced diapedesis across an ALCAM-/- in vitro BBB model under static but no longer under flow conditions. In contrast to the limited role of ALCAM in T cell extravasation across the BBB, we found a contribution of ALCAM to rolling, adhesion, and diapedesis of human CD14+ monocytes across the human BBB under flow and static conditions. Taken together, our study highlights the potential differences in the CNS expression of ALCAM in mouse and human and supports a prominent role for ALCAM in the multi-step extravasation of monocytes across the BBB.
Life Sciences

Details

Metrics

Logo image